Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #1,301 to #1,350.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Maehara O, et al. Neoplasia (2019) cited as Ref 398 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  2. (hist) ‎Kim JH, et al. Sci. Rep. (2018) cited as Ref 397 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  3. (hist) ‎Wang X, et al. Dev. Cell. (2019) cited as Ref 396 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  4. (hist) ‎Lebleu VS, et al. Nat. Cell Biol. (2014) cited as Ref 395 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  5. (hist) ‎Wang H, et al. Chin. J. Lung Cancer (2014) cited as Ref 394 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  6. (hist) ‎Rinaldi L, et al. eLife (2017) cited as Ref 393 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  7. (hist) ‎Liu L, et al. PLoS ONE (2013) cited as Ref 392 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  8. (hist) ‎Bigoni-Ordonez GD, et al. BMC Cancer (2018) cited as Ref 391 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  9. (hist) ‎Deng X, et al. Int. J. Mol. Med. (2015) cited as Ref 390 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  10. (hist) ‎Giampietri Claudia, et al. International Journal of Molecular Sciences (2017) cited as Ref 389 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  11. (hist) ‎Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  12. (hist) ‎Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  13. (hist) ‎Kramer K, et al. Oncogene (2016) cited as Ref 386 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  14. (hist) ‎Yousefnia S, et al. Gene (2018) cited as Ref 385 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  15. (hist) ‎Houseknecht KL, et al. Domest. Anim. Endocrinol. (2002) cited as Ref 384 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  16. (hist) ‎Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  17. (hist) ‎Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  18. (hist) ‎Elbrecht A, et al. Biochem. Biophys. Res. Commun. (1996) cited as Ref 381 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  19. (hist) ‎Kuenzli S, et al. Br. J. Dermatol. (2003) cited as Ref 380 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  20. (hist) ‎Peters JM, et al. Nat. Rev. Cancer (2012) cited as Ref 379 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  21. (hist) ‎Issemann I, et al. Nature (1990) cited as Ref 378 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  22. (hist) ‎Bonuccelli G, et al. Aging (Albany, NY) (2018) cited as Ref 377 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  23. (hist) ‎Chen WJ, et al. J. Nutr. Biochem. (2017) cited as Ref 376 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  24. (hist) ‎Karki R, et al. Nature (2016) cited as Ref 375 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  25. (hist) ‎Nishitani S, et al. PLoS ONE (2013) cited as Ref 374 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  26. (hist) ‎Huang EH, et al. Cancer Res. (2009) cited as Ref 373 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  27. (hist) ‎Yang C, et al. Int. J. Oncol. (2015) cited as Ref 372 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  28. (hist) ‎, et al. () cited as Ref 371 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  29. (hist) ‎Dubrovska A, et al. Proc. Natl Acad. Sci. USA (2009) cited as Ref 370 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  30. (hist) ‎Fitzgerald TL, et al. Adv. Biol. Regul. (2015) cited as Ref 369 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  31. (hist) ‎Chang L, et al. Cell death Dis. (2013) cited as Ref 368 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  32. (hist) ‎Deng J, et al. BMC Cancer (2019) cited as Ref 367 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  33. (hist) ‎Karki R, et al. Cell Cycle (2017) cited as Ref 366 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  34. (hist) ‎Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  35. (hist) ‎Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  36. (hist) ‎Offermann A, et al. Oncotarget (2017) cited as Ref 363 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  37. (hist) ‎Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  38. (hist) ‎Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  39. (hist) ‎Yuzugullu H, et al. Nat. Commun. (2015) cited as Ref 360 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  40. (hist) ‎Duan S, et al. Nat. Commun. (2015) cited as Ref 359 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  41. (hist) ‎Knowles MA, et al. Cancer metastasis Rev. (2009) cited as Ref 358 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  42. (hist) ‎Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  43. (hist) ‎Kim DH, et al. Cell (2002) cited as Ref 356 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  44. (hist) ‎Loewith R, et al. Mol. Cell (2002) cited as Ref 355 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  45. (hist) ‎Wang Q, et al. Br. J. Cancer (2017) cited as Ref 354 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  46. (hist) ‎Vanhaesebroeck B, et al. Nat. Rev. Mol. Cell. Biol. (2010) cited as Ref 353 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  47. (hist) ‎Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  48. (hist) ‎Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  49. (hist) ‎Jiang F, et al. PLoS ONE (2014) cited as Ref 350 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  50. (hist) ‎Muthusamy BP, et al. PLoS Biol. (2015) cited as Ref 349 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)